Immunosuppressive therapy in renal transplant patients according to patient immunological status.
Masri
M A
MA
Transplant and Immunology Unit, Rizk Hospital, Beirut, Lebanon.
Kamel
G
G
Barbari
A
A
Stephan
A
A
D000328:Adult; D015703:Antigens, CD / Q000032:analysis; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000517:prevention & control; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D016130:Immunophenotyping; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008297:Male; D008991:Monitoring, Physiologic; D011183:Postoperative Complications / Q000517:prevention & control; D014777:Virus Diseases / Q000517:prevention & control
D015703:Antigens, CD; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine